{
    "id": 31010,
    "fullName": "STK19 D89N",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "STK19 D89N does not lie within any known functional domains of the Stk19 protein (UniProt.org). D89N results in increased Nras phosphorylation and activation of Nras signaling, and increased colony formation and cell proliferation in culture (PMID: 30712867).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 15787,
                    "pubMedId": 30712867,
                    "title": "Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30712867"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 8859,
        "geneSymbol": "STK19",
        "terms": [
            "STK19",
            "D6S60",
            "D6S60E",
            "G11",
            "HLA-RP1",
            "RP1"
        ]
    },
    "variant": "D89N",
    "createDate": "09/17/2019",
    "updateDate": "10/10/2019",
    "referenceTranscriptCoordinates": {
        "id": 183503,
        "transcript": "NM_032454",
        "gDna": "chr6:g.31972346G>A",
        "cDna": "c.265G>A",
        "protein": "p.D89N",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 18486,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, ZT-12-037-01 treatment inhibited cell proliferation and colony formation in human melanoma cells expressing NRAS Q61R and STK19 D89N, and reduced tumor growth in a cell line xenograft model (PMID: 30712867).",
            "molecularProfile": {
                "id": 33327,
                "profileName": "NRAS Q61R STK19 D89N"
            },
            "therapy": {
                "id": 8729,
                "therapyName": "ZT-12-037-01",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 15787,
                    "pubMedId": 30712867,
                    "title": "Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30712867"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 33308,
            "profileName": "STK19 D89N",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 33327,
            "profileName": "NRAS Q61R STK19 D89N",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 183504,
            "transcript": "NM_004197",
            "gDna": "chr6:g.31972346G>A",
            "cDna": "c.265G>A",
            "protein": "p.D89N",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 183503,
            "transcript": "NM_032454",
            "gDna": "chr6:g.31972346G>A",
            "cDna": "c.265G>A",
            "protein": "p.D89N",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}